NADPH oxidase activation involves the assembly of membrane-localized cytochrome b 559 with the cytosolic components p47
Phagocytic cells possess an enzyme complex responsible for the generation of superoxide (O 2 . ) 1 in response to stimuli acting via membrane receptors. The complex, commonly referred to as NADPH oxidase (briefly, "oxidase"), is composed of a membrane-associated flavocytochrome b 559 (a heterodimer consisting of two subunits, gp91 phox and p22 phox ) and four cytosolic components, p47
phox , p67 phox , p40 phox , and the small GTPase Rac (Rac1 or 2) (reviewed in Refs. 1 and 2). The component responsible for electron transport from cytosolic NADPH to oxygen is gp91 phox , which contains the NADPH binding site and three redox stations, represented by FAD and two nonidentical hemes (3) (4) (5) . It is now apparent that homologues of gp91 phox (also known as Nox2) are found in a variety of mammalian nonphagocytic cells and in some lower organisms (the Nox/Duox family) (reviewed in Ref. 6) . Recently, homologues of p47 phox , known as Nox organizer 1 (NOXO1), and p67 phox , known as Nox activator 1 (NOXA1), were also described in such cells (reviewed in Ref. 7) . 2 The Nox proteins function as components of enzyme complexes generating oxygen radicals with a variety of roles, other than host defense, such as regulation of cell proliferation, signal transduction, oxidative modification of proteins, and oxygen sensing.
Activation of the oxidase, resulting in O 2 . production, is probably the consequence of a conformational change in gp91 phox , caused by the interaction of cytochrome b 559 with one or several of the cytosolic oxidase components (8) . Establishing contact with cytochrome b 559 requires the translocation to the plasma membrane of p47 phox , p67 phox , and Rac, a process known as oxidase assembly (reviewed in Refs. 9 and 10).
Stimulus-elicited activation of the oxidase in intact cells can be mimicked in a cell-free system, in which phagocyte membranes or purified and relipidated cytochrome b 559 are mixed with the cytosolic components p47 phox , p67 phox , and Rac, in the presence of an anionic amphiphile, serving as an activator (11) (12) (13) (14) (15) . The amphiphile acts by causing a conformational change in p47 phox (16) and, possibly, also by the induction of structural changes in cytochrome b 559 (17) .
The impairment of O 2 . production in the p47 phox -deficient form of chronic granulomatous disease shows that p47 phox is essential for oxidase assembly in vivo. Oxidase activation can, however, be achieved in vitro, in the absence of p47 phox , but not in the absence of p67
phox (18 -20) . These findings support a pivotal role for p67 phox in oxidase activation, a concept that was strengthened by the definition of an "activation domain" in p67
phox , consisting of residues 199 -210 (21) or 187-210 (22) . This domain was proposed to interact with gp91 phox and to control electron flow from NADPH to FAD (23) . Experimental evidence for this was recently provided by the findings that p67 phox binds to gp91 phox (24) and that Rac1 (24) and phosphorylated p47
phox (25) increase the binding of p67 phox to cytochrome b 559 . Versions of p67 phox truncated at residues 199 or 210, both bound to cytochrome b 559 (better than the intact protein) (25) , but only the form truncated at residue 210 was capable of supporting oxidase activation in vitro (21) . It was, consequently, suggested that binding of p67 phox to gp91 phox is required but not sufficient for oxidase activation and that a conformational change, involving the activation domain of p67 phox , is required (25) . A model of oxidase activation has been put forward (21, 23, 26) in which p67
phox functions as the "activator," whereas p47 phox and Rac serve as "organizers," in agreement with the recently adopted nomenclature of p67 phox and p47 phox homologues. To better understand the distinct organizer roles of p47 phox and Rac, we designed a cell-free activation system consisting of prenylated (geranylgeranylated) Rac1, which represents the physiological form of Rac1 in eukaryotic cells, phagocyte membranes, and p67 phox (26) . In this situation, interaction of p67 phox with cytochrome b 559 was made dependent exclusively on prenylated Rac and oxidase activation could be achieved in the absence of p47 phox and amphiphile. This suggested that, under certain conditions, targeting of Rac to the phagocyte membrane was sufficient for the induction of oxidase assembly.
Recently, Tamura and colleagues (27) and we (28) introduced a novel methodological approach to the study of oxidase activation, consisting of the construction of chimeric proteins, in which specific moieties of p67 phox and Rac1 were fused. The prototype chimera consisted of residues 1-212 of p67 phox and residues 1-192 of Rac1 and was named chimera 3 (28) . The moieties of the fused components comprised all the elements participating in the natural interaction between p67 phox and Rac. This is mediated by residues located in the pre-switch I and switch I regions and a more C-terminal region of Rac1 (29 -31) , interacting with residues in the tetratricopeptide repeat (TPR) domain in p67 phox (residues 1-153) (31, 32) . This interaction is dependent on Rac being in the GTP-bound form (29) and is of relatively low affinity (K d ϭ 1.7 M; see Ref. 31 ). The fusion of p67 phox with Rac1 generated a structure in which the components were brought permanently into close proximity and also resulted in a protein behaving as a bona fide small GTPase, capable of binding GTP/GDP in equimolar amounts (28) . In the design of chimera 3, the C terminus of Rac1 was placed at the C terminus of the chimera, enabling prenylation at Cys 189 in the Rac moiety. Thus, a set of p67 phox -Rac1 chimeras enzymatically prenylated in vitro were also generated (33) .
Non-prenylated chimera 3 was found to be an activator of the oxidase in vitro, in both GTP-and GDP-bound forms, in the presence of p47 phox and the anionic amphiphile lithium dodecyl sulfate (LiDS) (28) . In the GTP-bound form, it was also capable of moderate oxidase activation in the absence of p47 phox . Prenylated chimera 3, in the GTP-bound form, was found to elicit a high level of NADPH-dependent O 2 . production by phagocyte membranes, in the absence of both activator and p47 phox (33) . This report describes the effect of mutating specific residues in the p67 phox and Rac moieties of the prototype chimera 3
(p67 phox -(1-212)-Rac1-(1-192)) on its functional ability and supports a model of oxidase assembly in which Rac has a dual role of membrane tethering and "activation" of p67 phox .
EXPERIMENTAL PROCEDURES
Preparation of Phagocyte Membrane Vesicles-Membranes were prepared from mineral oil-elicited guinea pig peritoneal macrophages, as described earlier (28) . The membranes were solubilized by 40 mM n-octyl-␤-D-glucopyranoside, and membrane vesicles were generated by the removal of detergent by dialysis, as described before (34) .
Preparation of Non-chimeric Recombinant Proteins-p47 phox was prepared in baculovirus-infected Sf9 cells, as described earlier (35) . Non-prenylated Rac1, Rac1 mutants A27K, G30S, and Q61L, Rac1 truncated at residue 178 (Rac1-(1-178)) or 185 (Rac1-(1-185)), GDP dissociation inhibitor for Rho (Rho GDI), and p67
phox , truncated at residue 212 (p67 phox -(1-212)), were produced in Escherichia coli, as described earlier (26, 35, 36) . Non-prenylated CDC42Hs and RhoA were expressed in E. coli as glutathione S-transferase (GST) fusion proteins and purified by affinity chromatography on glutathione-agarose (Sigma), followed by cleavage by thrombin in situ, as described before (35) . All recombinant proteins listed above were expressed in E. coli BL21-CodonPlus TM competent cells (Stratagene).
Generation of Chimeras 3 and 5-Chimera p67
phox -(1-212)-Rac1-(1-192) (chimera 3) and chimera p67 phox -(1-212)-Rac1-(1-178) (chimera 5) were generated by polymerase chain reaction, joining DNA fragments from p67 phox with DNA fragments from Rac1, as described earlier (28) . The proteins were expressed as GST fusion proteins, essentially as described for Rac1 (35, 36) , but E. coli DH5␣ TM cells (Invitrogen) were used. Induction was with 0.1 mM isopropyl-␤-D-thiogalactopyranoside for 18 h at 18°C (chimera 3), and 0.4 mM isopropyl-␤-D-thiogalactopyranoside for 18 h at 22°C (chimera 5), in flasks shaken at 190 rpm. The chimeric proteins were purified by affinity chromatography on glutathione-agarose, followed by cleavage by thrombin in situ, as described before (35) .
Mutagenesis of Chimera 3-Eight mutants of chimera 3 (numbers 9 -16) were constructed and are illustrated in Fig. 1 . The numbering of mutant chimeric constructs continues the list of chimeras (numbers 1-8), as appearing in Ref. 28 . Single and multiple mutations were inserted into the p67 phox or Rac1 cDNA moieties of p67 phox -(1-212)-Rac1-(1-192) cDNA, in pGEX-2T (Amersham Biosciences), by PCR site-directed mutagenesis using specific oligonucleotide primers and PfuTurbo DNA polymerase. The QuikChange TM mutagenesis kit (Stratagene) was used, according to the manufacturer's instructions. The sequences of the mutant proteins were confirmed by dideoxynucleotide-based sequencing. Chimera 9 was generated from chimera 3, by converting Lys 183 to Gln, in the Rac1 moiety. Chimera 10 was generated from chimera 9, by converting both Lys 184 and Arg 185 to Gln, in the Rac1 moiety. Chimera 11 was generated from chimera 10, by converting Lys 186 to Gln, in the Rac1 moiety. Chimera 12 was generated from chimera 11, by converting both Arg 187 and Lys 188 to Gln, in the Rac moiety. Chimera 13 was generated from chimera 3, by converting Val 204 to Ala, in the p67 phox moiety. Chimera 14 was generated from chimera 3, by converting Arg 102 to Glu, in the p67 phox moiety. Chimera 15 was generated from chimera 3, by converting Ala 27 to Lys, in the Rac1 moiety. Chimera 16 was generated from chimera 3, by converting Gly 30 to Ser, in the Rac1 moiety. All mutant proteins were expressed in E. coli DH5␣ TM cells as GST fusion proteins and purified on glutathioneagarose, by the methodology used for the wild type chimeras.
Characterization of Mutant Chimeras-The protein content of mutant chimeric proteins was assessed by the method of Bradford (37) , using the microplate modification (Bulletin 1177 EG; Bio-Rad). The level of purity of the chimeric proteins was assessed by SDS-PAGE and staining by GelCode TM blue stain reagent (Pierce). All chimeras were assayed for the ability to bind GTP, by using the fluorescent analogue 2Ј-(or 3Ј)-O-(N-methylanthraniloyl)-␤,␥-imidoguanosine 5Ј-triphosphate (mant-GMP-PNP) (Molecular Probes), as described (28) . The identity and amount of nucleotides bound to the native or nucleotideexchanged forms of the recombinant mutant chimeras were determined by liberating the bound nucleotides from the protein, as described in Ref. 38 , and identifying the nucleotides by anion exchange chromatography on a Partisil 10 SAX column, as described in Ref. 39 .
Prenylation of Chimeras-Recombinant chimeric proteins were generated in E. coli in the unprocessed form and were geranylgeranylated in vitro by recombinant geranylgeranyltransferase type I, as described recently (33) . The level of prenylation was assessed by phase separation in Triton X-114 (40) .
Nucleotide Exchange-Chimeras and Rac1 were subjected to nucle-otide exchange from the native GDP-bound form to GTP␥S, GDP␤S, or GMP-PNP (all from Roche Applied Science), as described before (26) . A nucleotide to protein ratio of 10/1 was used for exchange to GTP␥S and GDP␤S, and a ratio of 20/1 was used for exchange to GMP-PNP.
NADPH Oxidase Activation in a Semirecombinant
Cell-free SystemMutant chimeras were tested for the ability to support oxidase activation in a semi-recombinant cell-free system as described before for non-prenylated (28) and prenylated (33) chimeras. When assaying nonprenylated chimeras, the cell-free system consisted of phagocyte membrane vesicles (at a concentration equivalent to 5 nM cytochrome b 559 heme), p47 phox (300 nM), chimeras (at concentrations that varied from 50 to 800 nM), and the amphiphilic activator LiDS (130 M). In selected experiments, oxidase activation was performed in the absence of p47 phox . Prenylated chimeras were assayed in a cell-free system consisting of phagocyte membrane vesicles (at a concentration equivalent to 5 nM cytochrome b 559 heme), and chimeras (at concentrations that varied from 50 to 800 nM), in the absence of p47 phox and an amphiphilic activator. Mixtures were incubated in 96-well microplates, in volumes of 200 l of assay buffer (36) per well, in duplicate, for 90 s at 25°C, followed by the addition of NADPH (240 M), to initiate O 2 . production.
This was quantified by the kinetics of cytochrome c reduction, as described (36) . In specific experiments, certain components were added to or removed from the standard mixtures; these variations are described under "Results." The ability of the p67 phox and Rac1 moieties of the various mutant chimeras to function independently of their fusion partners was measured as described for the wild type chimeras (28) . For testing the Rac1 moiety, the chimeras were subjected to exchange to GTP␥S.
Synthetic Rac1 C-terminal Peptide-A peptide corresponding to the C-terminal polybasic segment of Rac1 (residues 178 -192) was synthesized by Mimotopes Fisher Scientific, at a purity of 92%. The peptide was dissolved in 75% dimethyl sulfoxide, 25% water (v/v), at a concentration of 1.5 mM, and further diluted in oxidase assay buffer (36) to the desired final concentration.
Inhibition of Cell-free Oxidase Activation by Non-prenylated and Prenylated Chimera by Rac1 C-terminal Peptide and Rho GDI-
The standard cell-free assay methodologies for the two forms of chimeras were applied, with two exceptions. First, p47
phox was also omitted in experiments involving non-prenylated chimera, to make the two assays strictly comparable. Second, to compensate for the lower reaction rates in assays involving non-prenylated chimera, in the absence of p47 phox , the concentration of non-prenylated chimera was set at 600 nM, whereas prenylated chimera was used at 300 nM. The order of addition of the components in peptide inhibition experiments was: peptide, assay buffer with or without LiDS, membrane, and chimera, followed by 90 s incubation before the addition of NADPH. In experiments assessing inhibition by Rho GDI, the order of addition of the components to the reaction was: chimera, assay buffer with or without LiDS, and Rho GDI. These mixtures were incubated for 10 min at 25°C, followed by the addition of membrane, and, after 90 s, of NADPH. The degree of inhibition was calculated in relation to samples in which peptide or Rho GDI were replaced by an equivalent volume of buffer.
Characterization of Chimeras and Chimera-Rac Interactions by Gel Filtration-Chimeras or mixtures of chimeras and Rac1, exchanged to mant-GMP-PNP, were subjected to gel filtration on a Superdex 75 HR 10/30 fast performance liquid chromatography (FPLC) column (Amersham Biosciences). The column was eluted with a buffer consisting of 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 4 mM MgCl 2 , and 2 mM dithioerythritol. Chromatography was performed on a high performance liquid chromatography system (Waters), at a flow rate of 0.2 ml/min, at 4°C, and absorbance at 280 nm was measured continuously by a diode array detector (MD-1510, Jasco). When Rac, labeled with mant-GMP-PNP was present, the fluorescent signal (excitation ϭ 361 nm; emission ϭ 440 nm) was also recorded continuously, by passing the column eluate through a spectrofluorometer (FP-750; Jasco), fitted with a high performance liquid chromatography flow cell (MFC-132, Jasco). The column was standardized with molecular mass markers in the range 6,500 -66,000 (MW-GF-70 Kit, Sigma).
RESULTS

The Rationale on Which the Design of Mutant Chimeras Was
Based-All mutants were derived from chimera p67 phox -(1-212)-Rac1-(1-192) (chimera 3; Ref. 28) and are listed in Fig. 1 . Each mutant was meant to assess the importance of a certain residue or cluster of residues, in either the p67 phox or the Rac1 moiety, for the oxidase activating ability of the original chimera 3. Thus, chimeras 9 -12 were designed to examine the effect of modifying the number of basic residues at the C terminus of the Rac1 moiety. Chimera 13 was meant to test the importance of the activation domain in the p67 phox moiety. Chimeras 14 -16 were designed to investigate the need for an interaction between the TPR region of the p67 phox moiety and the switch I region of the Rac1 moiety, in addition to the engineered fusion between the two segments of the chimera. All mutant chimeras were assayed in both non-prenylated and prenylated forms.
Properties of Mutant Chimeras-All mutant chimeras were well expressed in the soluble fraction of E. coli, provided that the temperature during induction by isopropyl-␤-D-thiogalactopyranoside was kept at 18°C (22°C, for chimera 5). The mutant chimeras were found to be of the expected size when analyzed by SDS-PAGE. In native form, all chimeras were found to contain only GDP, at equimolar nucleotide/protein concentrations. They were found to be capable of exchanging GDP for GMP-PNP (or mant-GMP-PNP), when the concentration of free Mg 2ϩ was lowered to 0.5 M. When the ability of the p67 phox and Rac1 moieties of the mutant chimeras to function independently of their fusion partners was assessed, it was found that the p67 phox moiety was fully functional, with the exception of chimeras 13 and 14, in which activities were 50 -60% of the level measured in the parent chimera 3. The Rac1 moiety was found to be inactive in chimeras 9 -12, 15, and 16. Unexpectedly, the Rac1 moieties of chimeras 13 and 14, comprising the full-length of non-mutated Rac1, were only about half as active as in chimera 3.
Mutant chimeras were successfully prenylated in vitro, with the exception of chimera 16. The reason for poor prenylation of chimera 16 is unknown.
Both Positively Charged C-terminal Residues and the Prenyl Tail Participate in Oxidase Activation by p67
phox -Rac1 Chimeras-We have shown that chimera 5, a truncated form of chimera 3 lacking the polybasic C-terminal region of the Rac1 moiety, in the non-prenylated form, was incapable of oxidase activation (28) . Chimera 5, lacking Cys 189 could not be prenylated and, therefore, the relative importance of charge and prenylation in oxidase activation could not be assessed.
To get more quantitative information on the contribution of charge to activating ability, we compared the ability of four mutant chimeras, in which one (chimera 9), three (chimera 10), four (chimera 11), or all six (chimera 12) basic residue(s) at the C terminus of the Rac1 moiety were replaced by glutamine, to activate the oxidase in a cell-free system. The mutant chimeras were tested in non-prenylated and prenylated forms, using the p47 phox and amphiphile-dependent cell-free assay, for the nonprenylated mutants (28) , and the p47 phox and amphiphile-independent assay, for the prenylated mutants (33) . As seen in Fig. 2A , oxidase activation by non-prenylated chimeras was markedly dependent on the presence of all six basic residues. Thus, the exchange of a single basic residue (Lys 183 ) for Gln (chimera 9) resulted in a significant reduction in activating ability and chimeras possessing three, two, or no basic residues (chimeras 10, 11, and 12) were totally inactive. The situation was radically different when chimeras were prenylated. As seen in Fig. 2B , chimeras possessing five, three, or two Cterminal basic residues (chimeras 9, 10, and 11) were as active as the original chimera 3; a severe impairment in activating ability only became apparent upon the exchange of all six basic residues for neutral ones. These results indicate that the presence of a C-terminal prenyl tail almost fully compensates for the lack of the polybasic domain; however, the presence of a minimum of one or two basic residues is still required.
We have shown in the past that polybasic peptides, mimicking the sequence of the C terminus of Rac1, interfere with oxidase activation by non-prenylated (41) and prenylated (42) Rac1, and by non-prenylated chimera 3 (28) , in the presence of p47 phox and amphiphile, but not by prenylated Rac1, in the absence of p47 phox and amphiphile (42) . The effect was found not to be Rac1 sequence-specific but mediated by the overall positive charge of the peptide or other cationic compounds, found to exhibit an oxidase activation-inhibitory effect, such as neomycin (41, 42) . We now compared the ability of a synthetic peptide, corresponding to residues 178 -192 in Rac1 to influence oxidase activation by chimera 3 in either non-prenylated or prenylated forms. As apparent in Fig. 3A , Rac1 peptide 178 -192 exhibited dose-dependent inhibition of oxidase activation by non-prenylated chimera 3 but was lacking an inhibitory effect on activation by the prenylated form of the same chimera.
In another series of experiments, we made use of the observation that Rho GDI interferes with oxidase activation by prenylated Rac1, in the absence of amphiphile and p47 phox (26) , and investigated the effect of Rho GDI on oxidase activation by non-prenylated, as compared with prenylated chimera 3. As seen in Fig. 3B , Rho GDI had a marked dose-dependent inhibitory effect on oxidase activation by prenylated chimera 3, in the GDP-bound form, in the absence of p47 phox and amphiphile. It did not inhibit oxidase activation by prenylated Rac1-GTP␥S, for which Rho GDI possesses a lesser affinity (43) , and was also without effect on amphiphile-dependent oxidase activation by non-prenylated Rac1 (in both GDP-and GTP␥S-bound forms). These results provide further support for the conclusion, drawn from the experiments shown in Fig. 2 , that chimera 3, in non-prenylated form, depends on the C-terminal positive charge for activity, whereas the prenylated form is mostly, but not fully, dependent on the presence of the geranylgeranyl tail.
Intrachimeric Bonds between the p67 phox and Rac1 Moieties of Chimera 3 Are an Absolute Requirement for Oxidase Activating Ability-In recently published work (28), we noted three paradoxes, which were not easily explainable. The first was the lack of oxidase activation by chimeras 6 and 7, in the GTP␥S-bound form, both of which contained the full-length of Rac1 and the activation domain of p67 phox (residues 155-212 and 199 -212, respectively). The second was the finding that the GTPbound form of chimera 3 was a more potent activator than the GDP-bound form, especially in the absence of p47 phox . Because it is assumed that the nucleotide state of Rac1 determines the affinity of interaction with p67 phox , the existence of a permanent bond between the two moieties should have abolished the difference between the GTP-and GDP-bound forms. Finally, chimera 3 exchanged to GTP␥S or GDP␤S, eluted on gel filtration at different apparent molecular masses. We suggested that these findings could be explained by a requirement for the establishment of spontaneous intrachimeric bonds between the p67 phox and Rac1 moieties, for the chimera to be active. We now approached this issue by the introduction of a number of mutations in the prototype chimera 3, intended to disturb the ability of the p67 phox and Rac1 moieties to interact with each other and to interfere with the ability of the p67 phox FIG. 2. NADPH oxidase activation by mutants of chimera 3 in which basic residues at the C terminus of the Rac1 moiety were replaced by glutamine. One (chimera 9), three (chimera 10), four (chimera 11), or six (chimera 12) basic residues were replaced by glutamine. Mutants were assayed in non-prenylated (panel A) and prenylated (panel B) forms. A, oxidase activation was assayed in a cell-free system consisting of membrane (equivalent to 5 nM cytochrome b 559 heme), p47 phox (300 nM), non-prenylated chimera in the GTP␥S-bound form (0 -800 nM), and LiDS (130 M). B, oxidase activation was assayed in a cell-free system consisting of membrane (equivalent to 5 nM cytochrome b 559 heme), and prenylated chimera in the GTP␥S-bound form (0 -800 nM), in the absence of p47 phox and LiDS. Chimera 3, in nonprenylated or prenylated forms, served as positive reference. The results in both panels are mean Ϯ S.E. of three experiments. moiety to interact with cytochrome b 559 (see Fig. 1, chimeras  13-16) . Thus, chimera 13 contained a V204A mutation in the p67 phox moiety; this mutation, when introduced into wild type p67 phox , causes a severe impairment in its ability to support oxidase activation (21) . Chimera 14 contained a R102E mutation, also in the p67 phox moiety; this mutation, within the TPR domain, interferes with the ability of p67 phox to interact with Rac1 (32) . Chimeras 15 and 16 contain mutations A27K and G30S, respectively, in the Rac1 moiety; Rac1 mutants with the same replacements, were found to lack oxidase activating capacity (30) and were unable to interact with p67 phox (31) . The mutant chimeras were tested in both non-prenylated and prenylated forms, using the p47 phox and amphiphile-dependent, and the p47 phox and amphiphile-independent assays, respectively. Fig. 4 illustrates the results of these studies. Chimera 13, bearing mutation V204A in the p67 phox moiety, was a very poor activator, the prenylated mutant exhibiting a relatively larger loss of activity than the non-prenylated form. Chimeras 14, 15, and 16, comprising mutations R102E, in the p67 phox moiety, and A27K and G30S, in the Rac1 moiety, respectively, were all impaired in their ability to support oxidase activation in the cell-free system. In the non-prenylated form, the degree of functional impairment was, in decreasing order: chimera 15 (least active), chimera 14, and chimera 16 (most active) (Fig.  4A ). In the prenylated state, both chimeras 14 and 15 were totally inactive, up to a concentration of 800 nM (Fig. 4B) . Chimera 16 could not be assayed in prenylated form because of difficulty in obtaining sufficient amounts of material. These results demonstrate that the establishment of intrachimeric bonds between residues in the TPR domain of p67 phox and the switch I region of Rac1 is an absolute requirement for p67 phoxRac1 chimeras being capable of supporting oxidase activation.
A different explanation for these findings could be the formation of interchimeric bonds between the TPR domain of the p67 phox moiety of one chimeric unit and the switch I region of 
FIG. 4. NADPH oxidase activation by mutants of chimera 3 involving the activation domain of the p67
phox moiety or domains of interaction between the p67 phox and Rac1 moieties. Mutants V204A (chimera 13) and R102E (chimera 14), in the p67 phox moiety, and A27K (chimera 15) and G30S (chimera 16), in the Rac1 moiety, were assayed in non-prenylated (panel A) and prenylated (panel B) forms. A, oxidase activation was assayed in a cell-free system consisting of membrane (equivalent to 5 nM cytochrome b 559 heme), p47 phox (300 mM), non-prenylated chimera in the GTP␥S-bound form (0 -800 nM), and LiDS (130 M). B, oxidase activation was assayed in a cell-free system consisting of membrane (equivalent to 5 nM cytochrome b 559 heme), and prenylated chimera in the GTP␥S-bound form (0 -800 nM), in the absence of p47 phox and LiDS. Chimera 3, in non-prenylated or prenylated forms, served as positive reference. The results in both panels are mean Ϯ S.E. of three experiments.
the Rac1 moiety of a second chimeric unit, leading to the formation of chimera dimers. Theoretically, the formation of larger polymers is also possible. To clarify this issue, we performed gel filtration experiments in which the size of chimera 3 exchanged to GMP-PNP, capable of establishing p67 phox -Rac1 bonds, was compared with the size of native chimera 3 (in the GDP-bound form), incapable of establishing p67 phox -Rac1 bonds. As shown in Fig. 5 (panels A and B) , both chimeras were of a size close to the theoretical M r value of 45,800 (28) . Thus, chimera 3-GMP-PNP was found to have a M r of 45,090 Ϯ 640, whereas chimera 3-GDP had a M r of 48,990 Ϯ 950 3 (mean Ϯ S.E. of three experiments). Both values are compatible only with a monomeric structure; the larger apparent size of the GDP-bound form of chimera 3 suggests a more extended conformation, compared with a more globular shape of the GMP-PNP-bound form. What these experiments clearly show is the absence of dimers or larger polymers. The nature of the nucleotide(s) bound to the chimeras, purified and freed of unbound nucleotide by gel filtration, was determined by anion exchange chromatography. As seen in Fig. 5 (panels C and D) , these corresponded to the expected pattern: GDP only, on native chimera 3, and 94.2% GMP-PNP and 5.8% GDP, on chimera 3 exchanged to GMP-PNP. Fig. 4 suggest that Rac plays at least two roles in oxidase activation. One is to "pull" the chimera to the membrane, by virtue of the affinity of the polybasic domain and the geranylgeranyl tail for membrane phospholipids, enabling the interaction between the activation domain of the p67 phox moiety and cytochrome b 559 . For the performance of this function, the physical fusion between the two moieties of the chimera is sufficient. The second role could involve the induction of a conformational change in p67 phox , leading to an augmented affinity for gp91 phox or an enhanced ability to activate the electron flow in gp91 phox (24, 25) . We tested the reality of this second role by examining the effect of supplementing chimera 3 in the GDP-bound form or chimera 3 mutants, supposedly inactive because of the lack of intrachimeric bonds, with either free non-prenylated Rac1 or p67
Exogenous Rac1-GTP␥S but Not Exogenous p67 phox -(1-212) Restores the Activity of Mutant Chimeras Lacking Intrachimeric Bonds-The results illustrated in
phox -(1-212). We hypothesized that exogenous Rac1-GTP␥S would interact with the p67 phox moiety of the chimera (in the case of a mutation in the Rac1 moiety, preventing the formation of intrachimeric bonds), and exogenous p67
phox -(1-212) would interact with the Rac1 moiety (in the case of a mutation in the p67 phox moiety preventing the formation of intrachimeric bonds). Free Rac1-GTP␥S would also interact with the p67 phox moiety of chimera 3 in the GDP-bound form. An important methodological point was the necessity of running these assays in the absence of p47 phox , to avoid false positive results derived from the interaction of Rac1 or p67 phox -(1-212) with the p67 phox and Rac1 moieties of the chimeras, respectively, independently of their fusion partners. This was made possible by the fact that both non-prenylated (28) and prenylated (33) chimeras support oxidase activation in the absence of p47 phox , with the caveat that non-prenylated chimeras require the presence of an amphiphilic activator. The levels of activity of the non-prenylated and prenylated chimera 3, in the GTP␥S-bound form, are seen as the bars at the left in Fig. 6, A and B , respectively. The GDP-bound forms of the same chimeras were much less active; however, they reached activities equal to or exceeding those of the GTP␥S-bound forms, upon addition of free Rac1-GTP␥S but not of Rac1-GDP␤S or p67
phox -(1-212) (Fig. 6, A and B, first group of bars from the left). Non-prenylated and prenylated chimera 13-GTP␥S, inactive because of a V204A mutation in the activation domain of the p67 phox moiety, could not be repaired by supplementation with either free Rac1 or p67 phox -(1-212) (Fig. 6, A and B, second group of bars from the left) . Surprisingly, chimera 14-GTP␥S, inactive because of mutation R102E in the p67 phox moiety prevents the formation of intrachimeric bonds, could not be repaired by supplementation with p67 phox -(1-212) (Fig. 6, A and B, third group of bars from the left). Chimeras 15 and 16, however, comprising a A27K or G30S mutation in the Rac1 moiety and severely impaired in their ability to activate the oxidase, had their activities restored by supplementation with Rac1-GTP␥S and, in part, also by Rac1-GDP␤S (Fig. 6, A and B , the first and second group of bars from the right). Addition of free p67 phox -(1-212) did not repair chimeras 15 and 16, because mutations A27K or G30S in the Rac1 moiety, would be expected to result in an inability of the chimeras to bind p67 phox . In all situations in which Rac1-GTP␥S was found capable of repairing an inactive chimera (chimera 3-GDP, and chimeras 15 and 16, in the GTP␥S-bound form), no enhancement by Rac1-GTP␥S was observed when the chimeric constructs were replaced by free p67
phox -(1-212), combined with Rac1-GDP or with Rac1 mutants A27K or G30S, in the GTP␥S-bound form (Fig. 6, A and B, horizontally hatched bars) .
The most likely explanation for the enhancing effect of free Rac1-GTP␥S on p67 phox -Rac1 chimeras, either in the GDPbound form or with mutations in the switch I region of the Rac1 moiety, is an interaction between exogenous Rac1-GTP␥S and the p67 phox moiety of the chimeras. This would result in the formation of a tripartite structure, consisting of one p67
phox -(1-212) unit and two Rac1 units, one linked to p67
phox -(1-212) by fusion and the other, by "natural" interaction.
Restoration of Activity of Inactive Chimeras Requires a Switch I Region on Exogenous Rac1 Capable of Interaction with p67
phox -It was to be expected that exogenous Rac1-GTP␥S would interact with the p67 phox moiety of the chimera by the intermediary of the switch I region of the first and the TPR domain of the latter. To put this hypothesis to the test, we performed supplementation experiments of non-prenylated chimera 3, in the GDP-bound form, and of chimera 15, in the GTP␥S-bound form, with free Rac1-GTP␥S and Rac1 Q61L, in the absence of p47 phox . Supplementation with Rac1-GTP␥S mutants A27K or G30S or with two small GTPases of the Rho subfamily, CDC42Hs or RhoA (both in GTP␥S-bound form), all of which are unable to interact with p67 phox (29 -31) , served as negative controls. As apparent in Table I , only Rac1-GTP␥S and the dominant positive Rac1 mutant Q61L, known to be constitutively in the GTP-bound form (39, 44) , were able to repair the inactive chimeras.
Restoration of Inactive Chimeras by Exogenous Rac1 Requires Intact C Termini on Both the Rac1
Moiety of the Chimera and on the Exogenous Rac1-A possible contributing factor to the restoration of activity of inactive chimeras by supplementation with Rac1-GTP␥S is the C terminus of added Rac providing an additional membrane localizing signal. To examine this possibility and assess the relative importance of the C termini of the chimera and of the added Rac, we examined: 1) the restorative ability of Rac1-GTP␥S, truncated at residues 178 or 185, compared with that of intact Rac1-GTP␥S; and 2) the capacity of chimera 5, similar to chimera 3 but truncated at residue 178 of the Rac1 moiety (28) , to be repaired. In the canonical p47 phox and amphiphile-dependent cell-free system, Rac1-(1-178)-GTP␥S is inactive and the activity of Rac1-(1-185)-GTP␥S is only 21% of that of wild type Rac1-GTP␥S (Ref. 46 and our results). Chimera 5, in both GTP␥S-and GDPbound forms is incapable of oxidase activation (28) . As apparent in Table II , Rac1-(1-178)-GTP␥S and Rac1-(1-185)-GTP␥S, lacking all or half of the C-terminal basic residues, were severely impaired in their capacity to restore the activity of chimeras 3-GDP and 15-GTP␥S, in both non-prenylated and prenylated forms. As expected, chimera 5-GDP could not be repaired by either Rac1-GTP␥S, Rac1-(1-178)-GTP␥S or Rac1-(1-185)-GTP␥S.
Finally, we investigated whether one could demonstrate the formation of a stable complex in solution, consisting of the inactive chimera and the activating Rac1 (one could look upon this also as a tripartite structure, consisting of one p67 phox and two Rac1 moieties). For this purpose, we prepared mixtures, FIG. 6 . Reconstitution of the oxidase activating potential of inactive chimeras by exogenous Rac1. Chimera 3, in GDP-bound form, and mutants V204A (chimera 13) and R102E (chimera 14), in the p67 phox moiety, and A27K (chimera 15) and G30S (chimera 16), in the Rac1 moiety, in the GTP␥S-bound form, were incapable or partially incapable of supporting oxidase activation, in the absence of p47 phox . Supplementation of inactive chimeras in non-prenylated (panel A) and prenylated (panel B) forms with free Rac1-GTP␥S, but not with free p67 phox -(1-212), restores activity of chimera 3-GDP and chimeras 15 and 16, in the GTP␥S-bound form. A, oxidase activation was assayed in a cell-free system consisting of membrane (equivalent to 5 nM cytochrome b 559 heme), non-prenylated chimera (300 nM), and LiDS (130 M), in the absence of p47 phox , and in the absence or presence of free non-prenylated Rac1 (in GTP␥S-or GDP␤S-bound form) or p67 phox -(1-212), at a concentration of 300 nM. B, oxidase activation was assayed in a cell-free system consisting of membrane (equivalent to 5 nM cytochrome b 559 heme), prenylated chimera (200 nM), in the absence of p47 phox and LiDS, and in the absence or presence of free non-prenylated Rac1 (in GTP␥S or GDP␤S-bound form) or p67
phox -(1-212), at a concentration of 300 nM. Chimera 3-GTP␥S, non-prenylated or prenylated, served as positive reference. As negative reference served mixtures of free p67
phox -(1-212) with Rac1-GDP or Rac1 mutants A27K or G30S, in the GTP␥S-bound form (non-prenylated or prenylated). The results in both panels are mean Ϯ S.E. of three experiments. consisting of equimolar amounts of chimera 3-GDP or chimera 15-GTP␥S, and Rac1 exchanged to the fluorescent GTP analogue, mant-GMP-PNP, and applied these to a Superdex 75 FPLC gel filtration column. No evidence was found for the formation of a chimera-Rac1 complex, which would have appeared as superposed absorbance at 280 nm and fluorescent peaks, at an elution volume corresponding to a M r of ϳ70,000 (representing the sum of the M r values of the chimera and Rac1) (results not shown).
DISCUSSION
A novel approach to the elucidation of the molecular basis of NADPH oxidase assembly is the construction of chimeric proteins, consisting of part of or the entirety of one oxidase component fused to the whole or a part of a second oxidase component. The advantages of such an approach are: 1) to enable the study of low affinity interactions between two oxidase components by increasing the probability of domain-domain encounters, consequent to fusion; and 2) to build models of complex assembly, by generating artificial proteins composed of selected domains involved in protein-protein interactions, derived from two or more components. So far, this methodological approach has been applied to the design of p47 phox -p67 phox chimeras (45) and p67
phox -Rac1 chimeras (27, 28, 33) . p67 phox -Rac1 chimeras offer two further advantages: the ability to be prenylated at the C terminus of the Rac1 moiety, and the possibility of being assayed both in the native nucleotide state and following exchange to the desired exogenous nucleotide. In addition, both non-prenylated and prenylated chimeras are capable of supporting O 2 . production in a cell-free system in the absence of p47 phox (28, 33) , and prenylated chimeras are also active in the absence of an anionic amphiphile (33) .
One of the original expectations in the design of the p67 phoxRac1 chimeras was that the membrane tropism of the C terminus of the Rac1 moiety will make the chimeras into effective carriers of p67 phox to the vicinity of gp91 phox in the membrane. We now show that the six basic residues, KKRKRK, at positions 183-188 of the Rac1 moiety, are essential for the function of the nonprenylated chimera, as also reported for free Rac1 (46) . Prenylation of the chimera almost completely relieves the need for C-terminal positive charge but, in the total absence of such charge, prenylation is not sufficient for conferring activity. These data are in good agreement with the higher efficiency of free prenylated Rac1 (6 basic residues) compared with prenylated Rac2 (3 basic residues) (46) , and with the superior membrane association of prenylated chimeras 2 and 3 (containing residues 183-188), in comparison to chimera 1, lacking the polybasic domain (33) . They also corroborate the finding that prenylated Rac1 has a higher affinity for negatively charged lipid vesicles than for neutral ones (42) .
Despite the importance of charge, our results suggest that the prenyl tail serves as the dominant mediator of membrane tropism of Rac1 in vivo. Support for this view is also provided by the lack of inhibitory effect of a polybasic Rac1 C-terminal peptide on activation by prenylated chimera, in contrast to the marked inhibitory effect of Rho GDI in the same situation. The selectivity of Rho GDI-mediated inhibition for chimera 3-GDP, as opposed to chimera 3-GTP␥S, could be a reflection of its higher affinity for the GDP-bound form of the Rac1 moiety (43) . Alternatively, it could be because of the inaccessibility of the Rac1 moiety, within the GTP␥S-bound form of the chimera, to Rho GDI, resulting from the assumption of a "closed" conformation (see a later section of the "Discussion").
What came as a surprise was the severe impairment of oxidase activating ability of chimeras with mutations affecting residues in the TPR domain of the p67 phox moiety (R102E) and the switch I region of the Rac1 moiety (A27K,G30S). It is apparent that despite the engineered fusion among the two moieties, the TPR domain of the p67 phox moiety has to interact with the switch I region of the Rac1 moiety to endow the chimera with oxidase activating ability.
We propose that intrachimeric bonds are required for the induction of a conformational change in the activation domain of the p67 phox moiety. This conformational change is secondary to the interaction of the TPR region of the p67 phox moiety with the Rac1 moiety and might be the result of a rearrangement in intramolecular interactions within the p67 phox moiety (see Ref. 31) . Strong support for the veracity of this hypothesis is offered by the results of experiments in which chimeras, supposedly inactive because of the lack of intrachimeric bonds, were restored to activity by the addition of exogenous Rac1-GTP␥S or Rac1 Q61L, which is constitutively in the GTP-bound form ( Fig. 6 and Tables I and II) .
At the structural level, this means that the chimeras assume either a closed (active) or an open (inactive) conformation, depending on the presence (Fig. 7A) or absence (Fig. 7B ) of intrachimeric bonds, respectively. In the absence of intrachimeric bonds, exogenous Rac1 serves as a substitute, by establishing protein-protein interactions with the p67 phox moiety and inducing a conformational change in the activation domain of the p67 phox moiety (Fig. 7, C and D) . We found that the ability of Rac1-GTP␥S to repair the inactive chimeras 3-GDP and 15-GTP␥S was conditional upon the presence of intact C termini on both the Rac1 moiety of the chimera and on the exogenous Rac1. The probable explanation for this is that the chances of added Rac to form a complex with the chimera are likely to be increased by the co-localization of chimera (via the C terminus of its Rac1 moiety) and added Rac1 (via its C terminus) to the membrane. In the absence of such co-localization, binding of Rac1 to the chimera would depend phox -Rac1 chimeras by free Rac1-GTP␥S requires intact C termini on both the Rac1 moiety of the chimera and on the added free Rac1 Oxidase activation was assayed in a cell-free system consisting of membrane (equivalent to 5 nM cytochrome b 559 heme), non-prenylated or prenylated chimeras (300 nM), in the absence of p47 phox , and in the absence or presence of non-prenylated Rac1 or Rac1 mutants, listed in the first column (300 nM). When the chimera was non-prenylated, activation was in the presence of LiDS (130 M): when the chimera was prenylated, activation was in the absence of LiDS. The results represent mean Ϯ S.E. of three experiments. exclusively on the affinity of Rac1-GTP␥S for the p67 phox moiety of the chimera, which is relatively low (31) . Support for this explanation is also offered by our inability to demonstrate the existence of stable Rac1-chimera complexes in solution, by gel filtration.
Restoration of inactive chimeras by exogenous Rac1 contrasts with the failure of exogenous p67 phox -(1-212) to restore the activity of chimeras 3-GDP and 14-GTP␥S. The inability of exogenous p67
phox -(1-212) to repair the inactive chimera 3-GDP is because of the fact that p67
phox -(1-212) will not bind to the Rac1 moiety of the chimera, in the GDP-bound form. The inability of exogenous p67
phox -(1-212) to repair chimera 14-GTP␥S is because of two reasons. First, p67
phox -(1-212) lacks a membrane localizing signal and its chances of forming a complex with the membrane-bound chimera are very low. Second, should p67 phox -(1-212) bind to the Rac1 moiety of the chimera, the conformational change would take place in the exogenous p67
phox -(1-212), unlikely to make contact with gp91 phox (Fig. 7E ). We have initiated structural studies to test our proposal of open and closed conformations of the chimeras. Preliminary results, using small-angle x-ray scattering (47) in solution, support our model. Thus, native chimera, with bound GDP, assumes a more extended conformation than the same chimera, with bound GMP-PNP, as judged by both D max (maximum diameter) and R g (the radius of gyration). 4 Our findings lead to a novel interpretation of the roles of Rac and p47 phox in oxidase assembly. In the intact cell, p47 phox and Rac share the task of organizers, leading to the optimal juxtaposition of p67 phox and cytochrome b 559 and the consequent induction of electron flow. However, in vitro studies demonstrate that the roles of p47 phox and Rac are not interchangeable, as evidenced by the finding that oxidase assembly can be induced in a cell-free system by combining membrane with p67 phox ϩ Rac or a p67 phox -Rac1 chimera, in the absence of p47 phox (18 -20, 27, 28, 33) , but not with p67 phox ϩ p47 phox or a p47 phox -p67 phox chimera, in the absence of Rac (18 -20, 45 ). This suggests that, although p47 phox and Rac might share the mechanical task of anchoring p67 phox to the membrane, Rac performs an additional function, not shared by p47
phox , that of inducing an "activating" conformational change in p67 phox . 1-212) . A, for the GTP␥S-bound form of chimera 3, capable of oxidase activation, the existence of intrachimeric bonds is proposed, inducing a conformational change in the activation domain of the p67 phox moiety of the chimera. No intrachimeric bonds are expected to be present in chimera 3-GDP (B and C), and in chimeras 14 (E), and 15 and 16 (D), in the GTP␥S-bound form. Chimera 3-GDP and chimeras 15 and 16, in the GTP␥S-bound form, can be restored to activity by supplementation with free Rac1-GTP␥S, leading to a conformational change in the activation domain of the p67 phox moiety of the chimera. Chimera 14-GTP␥S cannot be restored to activity by supplementation with free p67
phox -(1-212); in this situation, the conformational change is expected to occur in the activation domain of the exogenous p67 phox .
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